Cargando…

Immune effectors required for the therapeutic activity of vorinostat

Detalles Bibliográficos
Autores principales: Kepp, Oliver, Galluzzi, Lorenzo, Kroemer, Guido
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Landes Bioscience 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891759/
https://www.ncbi.nlm.nih.gov/pubmed/24475375
http://dx.doi.org/10.4161/onci.27157
_version_ 1782299420705947648
author Kepp, Oliver
Galluzzi, Lorenzo
Kroemer, Guido
author_facet Kepp, Oliver
Galluzzi, Lorenzo
Kroemer, Guido
author_sort Kepp, Oliver
collection PubMed
description
format Online
Article
Text
id pubmed-3891759
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Landes Bioscience
record_format MEDLINE/PubMed
spelling pubmed-38917592014-01-28 Immune effectors required for the therapeutic activity of vorinostat Kepp, Oliver Galluzzi, Lorenzo Kroemer, Guido Oncoimmunology Editorial Landes Bioscience 2013-11-01 2013-11-13 /pmc/articles/PMC3891759/ /pubmed/24475375 http://dx.doi.org/10.4161/onci.27157 Text en Copyright © 2013 Landes Bioscience http://creativecommons.org/licenses/by-nc/3.0/ This is an open-access article licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License. The article may be redistributed, reproduced, and reused for non-commercial purposes, provided the original source is properly cited.
spellingShingle Editorial
Kepp, Oliver
Galluzzi, Lorenzo
Kroemer, Guido
Immune effectors required for the therapeutic activity of vorinostat
title Immune effectors required for the therapeutic activity of vorinostat
title_full Immune effectors required for the therapeutic activity of vorinostat
title_fullStr Immune effectors required for the therapeutic activity of vorinostat
title_full_unstemmed Immune effectors required for the therapeutic activity of vorinostat
title_short Immune effectors required for the therapeutic activity of vorinostat
title_sort immune effectors required for the therapeutic activity of vorinostat
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3891759/
https://www.ncbi.nlm.nih.gov/pubmed/24475375
http://dx.doi.org/10.4161/onci.27157
work_keys_str_mv AT keppoliver immuneeffectorsrequiredforthetherapeuticactivityofvorinostat
AT galluzzilorenzo immuneeffectorsrequiredforthetherapeuticactivityofvorinostat
AT kroemerguido immuneeffectorsrequiredforthetherapeuticactivityofvorinostat